Effect of polypharmacy on bleeding with rivaroxaban versus vitamin K antagonist for treatment of venous thromboembolism

por Bistervels, Ingrid M., Bavalia, Roisin, Gebel, Martin, Lensing, Anthonie W. A., Middeldorp, Saskia, Prins, Martin H., Coppens, Michiel
Publicado 2022

Use of Prestudy Heparin Did Not Influence the Efficacy and Safety of Rivaroxaban in Patients Treated for Symptomatic Venous Thromboem‐bolism in the EINSTEIN DVT and EINSTEIN PE Stu...

por Prandoni, Paolo, Prins, Martin H., Cohen, Alexander T., Müller, Katharina, Pap, Ákos F., Tewes, Miriam C., Lensing, Anthonie W. A.
Publicado 2015

Elastic compression stockings for prevention of the post-thrombotic syndrome in patients with and without residual vein thrombosis and/or popliteal valve reflux

por Prandoni, Paolo, Lensing, Anthonie W.A., Prins, Martin H., Villalta, Sabina, Pesavento, Raffaele, Tormene, Daniela, Noventa, Franco, Palareti, Gualtiero
Publicado 2021

Sex‐specific differences in clot resolution 3 weeks after acute pulmonary embolism managed with anticoagulants—A substudy of the EINSTEIN‐PE study

por Wiegers, Hanke M. G., van Es, Josien, Pap, Ákos F., Lensing, Anthonie W. A., Middeldorp, Saskia, Scheres, Luuk J. J.
Publicado 2021

Treatment of Pulmonary Embolism With Rivaroxaban: Outcomes by Simplified Pulmonary Embolism Severity Index Score from a Post Hoc Analysis of the EINSTEIN PE Study

por Fermann, Gregory J, Erkens, Petra M G, Prins, Martin H, Wells, Philip S, Pap, Ákos F, Lensing, Anthonie W A, Kline, Jeffrey
Publicado 2015

Comparison of Four Bleeding Risk Scores to Identify Rivaroxaban‐treated Patients With Venous Thromboembolism at Low Risk for Major Bleeding

por Kline, Jeffrey A., Jimenez, David, Courtney, D. Mark, Ianus, Juliana, Cao, Lynn, Lensing, Anthonie W.A., Prins, Martin H., Wells, Philip S.
Publicado 2016

Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study

por Willmann, Stefan, Thelen, Kirstin, Kubitza, Dagmar, Lensing, Anthonie W. A., Frede, Matthias, Coboeken, Katrin, Stampfuss, Jan, Burghaus, Rolf, Mück, Wolfgang, Lippert, Jörg
Publicado 2018

Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high‐ and low‐dose rivaroxaban with aspirin

por Boonyawat, Kochawan, Lensing, Anthonie W. A., Prins, Martin H., Beyer‐Westendorf, Jan, Prandoni, Paolo, Martinelli, Ida, Middeldorp, Saskia, Pap, Akos F., Weitz, Jeffrey I., Crowther, Mark
Publicado 2021

Erratum to: ‘Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program’

por Yamada, Norikazu, Hirayama, Atsushi, Maeda, Hideaki, Sakagami, Satoru, Shikata, Hiroo, Prins, Martin H., Lensing, Anthonie W. A., Kato, Masaharu, Onuma, Junichi, Miyamoto, Yuki, Iekushi, Kazuma, Kajikawa, Mariko
Publicado 2016

Exploratory evaluation of pharmacodynamics, pharmacokinetics and safety of rivaroxaban in children and adolescents: an EINSTEIN-Jr phase I study

por Kubitza, Dagmar, Willmann, Stefan, Becka, Michael, Thelen, Kirstin, Young, Guy, Brandão, Leonardo R., Monagle, Paul, Male, Christoph, Chan, Anthony, Kennet, Gili, Martinelli, Ida, Saracco, Paola, Lensing, Anthonie W. A.
Publicado 2018

Population pharmacokinetic analysis of rivaroxaban in children and comparison to prospective physiologically‐based pharmacokinetic predictions

por Willmann, Stefan, Coboeken, Katrin, Zhang, Yang, Mayer, Hannah, Ince, Ibrahim, Mesic, Emir, Thelen, Kirstin, Kubitza, Dagmar, Lensing, Anthonie W. A., Yang, Haitao, Zhu, Peijuan, Mück, Wolfgang, Drenth, Henk‐Jan, Lippert, Jörg
Publicado 2021

PK/PD modeling of FXI antisense oligonucleotides to bridge the dose‐FXI activity relation from healthy volunteers to end‐stage renal disease patients

por Willmann, Stefan, Marostica, Eleonora, Snelder, Nelleke, Solms, Alexander, Jensen, Markus, Lobmeyer, Maximilian, Lensing, Anthonie W. A., Bethune, Claudette, Morgan, Erin, Yu, Rosie Z., Wang, Yanfeng, Jung, Shiangtung W., Geary, Richard, Bhanot, Sanjay
Publicado 2021

Anticoagulation in pediatric cancer–associated venous thromboembolism: a subgroup analysis of EINSTEIN-Jr

por Palumbo, Joseph S., Lensing, Anthonie W.A., Brandão, Leonardo R., Hooimeijer, Hélène L., Kenet, Gili, van Ommen, Heleen, Pap, Akos F., Majumder, Madhurima, Kubitza, Dagmar, Thelen, Kirstin, Willmann, Stefan, Prins, Martin H., Monagle, Paul, Male, Christoph
Publicado 2022

Rivaroxaban versus standard anticoagulation for acute venous thromboembolism in childhood. Design of the EINSTEIN-Jr phase III study

por Lensing, Anthonie W. A., Male, Christoph, Young, Guy, Kubitza, Dagmar, Kenet, Gili, Patricia Massicotte, M., Chan, Anthony, Molinari, Angelo C., Nowak-Goettl, Ulrike, Pap, Ákos F., Adalbo, Ivet, Smith, William T., Mason, Amy, Thelen, Kirstin, Berkowitz, Scott D., Crowther, Mark, Schmidt, Stephan, Price, Victoria, Prins, Martin H., Monagle, Paul
Publicado 2018

Clinical presentation and therapeutic management of venous thrombosis in young children: a retrospective analysis

por Chan, Anthony, Lensing, Anthonie W. A., Kubitza, Dagmar, Brown, Grahaem, Elorza, Dolores, Ybarra, Marta, Halton, Jacqueline, Grunt, Sebastian, Kenet, Gili, Bonnet, Damien, Santamaria, Amparo, Saracco, Paola, Biss, Tina, Climent, Francesco, Connor, Philip, Palumbo, Joseph, Thelen, Kirstin, Smith, William T., Mason, Amy, Adalbo, Ivet, Berkowitz, Scott D., Hurst, Eva, van Kesteren, Jeroen, Young, Guy, Monagle, Paul
Publicado 2018

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review...

por Khan, Faizan, Rahman, Alvi, Carrier, Marc, Kearon, Clive, Weitz, Jeffrey I, Schulman, Sam, Couturaud, Francis, Eichinger, Sabine, Kyrle, Paul A, Becattini, Cecilia, Agnelli, Giancarlo, Brighton, Timothy A, Lensing, Anthonie W A, Prins, Martin H, Sabri, Elham, Hutton, Brian, Pinede, Laurent, Cushman, Mary, Palareti, Gualtiero, Wells, George A, Prandoni, Paolo, Büller, Harry R, Rodger, Marc A
Publicado 2019